Over 6x Capacity Jump! This Chemical Company Completes Major Expansion

Patel Chem Specialities Ltd has completed the second expansion of its Talod manufacturing facility in Gujarat, taking annual production capacity to 4,500 MT from 720 MT. The increase represents a 6.25-fold expansion in capacity, or a 525 per cent increase over the pre-expansion level.

Trial batches have commenced at the expanded unit and commercial production is expected to begin shortly, the company said. The project involved capital expenditure of around Rs 20 crore, funded through Bank loans and internal accruals.

The expansion is aimed at meeting anticipated demand growth and reducing delivery timelines for customers. Patel Chem manufactures pharmaceutical excipients and specialty chemicals, including cellulose- and starch-based products used in pharmaceutical and nutraceutical formulations. Its portfolio includes Sodium Carboxymethyl Cellulose, Microcrystalline Cellulose, Sodium Starch Glycolate and Croscarmellose Sodium, alongside Sodium Monochloroacetate, a chemical intermediate.

At peak utilisation, the Talod plant could generate annual revenue of about Rs 85 crore to Rs 100 crore, according to the company. This is equivalent to roughly 62 per cent to 73 per cent of Patel Chem's revenue from operations of Rs 137.26 crore in FY2025-26. The comparison highlights the scale of the new facility, although actual revenue contribution will depend on product mix, realisations, customer approvals and the pace at which capacity is utilised.

Managing Director Bhupesh Patel said the additional capacity would help the company serve growing demand and improve delivery schedules. He added that the company was preparing to leverage the expanded facility for future growth after the start of commercial production.

The Talod commissioning is consistent with Patel Chem's stated strategy of expanding manufacturing infrastructure for its core excipient portfolio. In FY2025-26, the company reported a 30.6 per cent rise in revenue from operations to Rs 137.26 crore, while profit after Tax increased to Rs 12.55 crore from Rs 10.57 crore in the previous year. However, EBITDA margin narrowed to 13.58 per cent from 14.97 per cent, indicating that the financial benefit of higher capacity will also depend on operating efficiency and input-cost management.

Raw material costs remain a relevant consideration for the chemical manufacturer. Key inputs include monochloroacetic acid, soda ash and starch, and changes in their prices or availability can influence production economics. The company also needs to convert trial production into commercial supplies and build utilisation levels before the full capacity potential can be reflected in financial performance.

Patel Chem is also developing another manufacturing facility at Indrad in Gujarat's Mehsana district, which is planned to produce Croscarmellose Sodium, Sodium Starch Glycolate and Calcium Carboxymethyl Cellulose with an expected installed capacity of 6,012 MTPA. The Talod expansion therefore forms part of a wider manufacturing build-out rather than a standalone capacity addition.

As of 3.05 pm on October 7, 2026, Patel Chem shares were trading at Rs 142.75, down 3.77 per cent from the previous close of Rs 148.35. The stock has gained 37.26 per cent over the past year, compared with a 4.54 per cent decline in the BSE 500, an outperformance of about 41.8 percentage points.

Disclaimer: The article is for informational purposes only and not investment advice.